Advertisement

Altered Expression of FHIT in Esophageal Neoplasm

  • Masaki Mori
  • Koshi Mimori
  • Hiroshi Inoue
  • Yoichi Tanaka
  • Kay Huebner
  • Carlo M. Croce
Conference paper

Abstract

The FHIT (fragile histidine triad) gene located at chromosome region 3p14 has been reported to be deleted in a variety of common tumors including esophageal carcinoma

Keywords

Esophageal Carcinoma Esophageal Neoplasm Environmental Carcinogen Light Drinker FHIT Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3, 8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597PubMedCrossRefGoogle Scholar
  2. 2.
    Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K, Croce CM (1997) Sequence of the FRA3B common fragile region: implications for the mechanisms of FHIT deletion. Proc Natl Acad Sci USA 94:14584–14589PubMedCrossRefGoogle Scholar
  3. 3.
    Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM (1999) Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci USA 96:7456–7461PubMedCrossRefGoogle Scholar
  4. 4.
    Michael D, Beer DG, Wilke CW, Miller DE, Glover TW (1997) Frequent deletions of FHIT and FRA3B in Barrett’s metaplasia and esophageal adenocarcinomas. Oncogene 15:1653–1659PubMedCrossRefGoogle Scholar
  5. 5.
    Nelson HN, Wieneke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT (1998) Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos, Cancer Res 58:1804–1807PubMedGoogle Scholar
  6. 6.
    Morita M, Kuwano H, Ohno S, Sugimachi K, Seo Y, Tomoda H, Furusawa M, Nakashima T (1994) Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 58:207–210PubMedCrossRefGoogle Scholar
  7. 7.
    Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S (1998) Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58:5032–5037PubMedGoogle Scholar
  8. 8.
    Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD, Jr, Chen LB (1993) Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8:2821–2826PubMedGoogle Scholar
  9. 9.
    Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM (1999) FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res 59:3866–3869PubMedGoogle Scholar
  10. 10.
    Ishi H, Baffa R, Numata S, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM (1999) The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Nat! Acad Sci USA 96:3923–3933Google Scholar
  11. 11.
    Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K (1998) Loss of FHIT expression in gastric carcinoma. Cancer Res, 58:4708–4714PubMedGoogle Scholar
  12. 12.
    Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, Sard L, Tagliabue E, Greco A, Fusetti L, Schwartz G, Pierotti MA, Croce CM, Huebner K (1997) Replacement of FHIT in cancer cells suppress tumorigenicity. Proc Nat! Acad Sci USA 94:13771–13776PubMedCrossRefGoogle Scholar
  13. 13.
    Sugimachi K (1998) Advances in the surgical treatment of oesophageal Cancer. Br J Surg 85:289–290PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2002

Authors and Affiliations

  • Masaki Mori
    • 1
  • Koshi Mimori
    • 1
  • Hiroshi Inoue
    • 1
  • Yoichi Tanaka
    • 2
  • Kay Huebner
    • 3
  • Carlo M. Croce
    • 3
  1. 1.Department of Surgery, Medical Institute of BioregulationKyushu UniversityBeppuJapan
  2. 2.Department of SurgerySaitama Cancer CenterSaitamaJapan
  3. 3.Kimmel Cancer InstituteThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations